ArticleDiscover oncology2025
Somatostatin receptor expression in multiple hemangiomas.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- "Not All That Glitters Is Gold": Paraspinal Cavernous Hemangioma Mimicking Paraganglioma on Somatostatin Receptor PET/CT.Diagnostics (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlthough hemangiomas frequently occur in the skin, mucosa, liver, and brain, they are rarely observed in the abdominal cavity or retroperitoneum. Moreover, the expression of the somatostatin receptor (SSTR), a member of the G protein-coupled receptor superfamily, in hemangiomas is an uncommon phenomenon. Here, we report the case of a patient with hemangioma expressing somatostatin receptors. To date, this is the second documented case of multiple hemangiomas in which somatostatin receptors are expressed (Chua et al. Clin Nucl Med 47:321-323, 2022; Müssig et al. J Clin Endocrinol Metab 94:4123-4124, 2009). CASE PRESENTATION: A 66-year-old female with normal blood pressure and occasional episodes of hypertension but no symptoms, such as headache, chest pain, or palpitations, was found to have multiple hypervascular lesions in the retroperitoneum, rectouterine pouch, abdominal wall, and small bowel wall on pelvic contrast-enhanced CT. On the basis of the imaging findings from the CT and PET scans, the initial diagnosis was metastatic paraganglioma. The patient underwent laparoscopic surgery, and the tumors in the retroperitoneum and abdominal wall were successfully removed. Histopathological diagnosis confirmed hemangioma. Immunohistochemistry revealed positive expression of the endothelial cell markers CD31(+) and CD34(+), as well as expression of somatostatin receptor 2 (SSTR2), in some cytoplasmic cells.
conclusionThis case highlights the rare expression of somatostatin receptors in hemangiomas, which may provide insights into their biological behavior and potential therapeutic targets. Increased awareness of such atypical presentations can improve diagnostic accuracy and inform clinical management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.